HMGN Stock Chart & Stats
$0.02
$0.00(0.00%)
At close: 4:00 PM EDT
$0.02
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.02 - $0.04
Previous CloseN/A
Volume100.00
Average Volume (3M)6.00
Market Cap
$3.10K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2137.85
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding15,500,000
10 Day Avg. Volume20
30 Day Avg. Volume6
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HMGN FAQ
What was Hemagen Diagnostics Inc’s price range in the past 12 months?
Hemagen Diagnostics Inc lowest stock price was $0.01 and its highest was $0.04 in the past 12 months.
What is Hemagen Diagnostics Inc’s market cap?
Hemagen Diagnostics Inc’s market cap is $3.10K.
When is Hemagen Diagnostics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Hemagen Diagnostics Inc’s earnings last quarter?
Currently, no data Available
Is Hemagen Diagnostics Inc overvalued?
According to Wall Street analysts Hemagen Diagnostics Inc’s price is currently Overvalued.
Does Hemagen Diagnostics Inc pay dividends?
Hemagen Diagnostics Inc does not currently pay dividends.
What is Hemagen Diagnostics Inc’s EPS estimate?
Hemagen Diagnostics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hemagen Diagnostics Inc have?
Hemagen Diagnostics Inc has 15,500,000 shares outstanding.
What happened to Hemagen Diagnostics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Hemagen Diagnostics Inc?
Currently, no hedge funds are holding shares in HMGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Hemagen Diagnostics Inc
Hemagen Diagnostics, Inc., a global biotechnology firm, specializes in delivering clinical diagnostic solutions for both human and animal health. The company designs, manufactures, and distributes the VIRGO product line, a series of human clinical immunoassays used for identifying autoimmune and infectious diseases, as well as acute phase proteins. Its comprehensive human diagnostic portfolio also encompasses Universal IFA components, various supplies, controls, calibrators, accessories, H-rotors, reagents, electrodes, equipment, and specialized assays covering conditions such as Chagas, acute phase proteins, and cytokines. For the veterinary market, Hemagen Diagnostics provides diagnostic equipment, reagents, consumables, accessories, and electrodes crucial for chemistry, hematology, and electrolyte analysis. The company reaches a diverse customer base, including laboratories, hospitals, and blood banks, through both direct sales and an extensive distribution network. Established in 1985, Hemagen Diagnostics maintains its headquarters in Columbia, Maryland.
Technical Analysis
Ownership Overview
―
Insiders
―
Mutual Funds
0.33% Other Institutional Investors
99.67% Public Companies and
Individual Investors